Brooklyn Investment Group’s ProKidney PROK Stock Holding History

Brooklyn Investment Group’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-728	Closed	-$432	–	2168
2025 Q2	$432	Buy	+728	New	+$567	﹤0.01%	3115

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brooklyn Investment Group's PROK Position: Q3 2025 in Review

Brooklyn Investment Group sold out of ProKidney (PROK) in Q3 2025, closing a stake of 728 shares — an estimated $432 sold.

Brooklyn Investment Group first reported a position in PROK in Q2 2025 and held it in 1 quarter. The position peaked at $432 in Q2 2025. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

Brooklyn Investment Group reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
Brooklyn Investment Group sold 728 ProKidney shares in Q3 2025, an estimated $432.
Brooklyn Investment Group first reported a position in ProKidney in Q2 2025 and held it in 1 quarter.
Brooklyn Investment Group's ProKidney position peaked at $432 in Q2 2025.
56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.